NXS 0.00% 15.5¢ next science limited

Ann: XPERIENCE study findings published, page-2

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 4,567 Posts.
    lightbulb Created with Sketch. 793
    "BENEFICIAL EFFECTS OF A NOVEL INTRAOPERATIVE SURGICAL IRRIGANT ON POST-OPERATIVE KNEE SWELLING AND LIMB FUNCTION IN PRIMARY TOTAL KNEE ARTHROPLASTY | Published in Journal of Orthopaedic Experience & Innovation (scholasticahq.com)


    This pilot study signifies the utility of XP as a multifunctional, intraoperative surgical irrigation solution which has demonstrable benefits of reducing PO swelling with the potential to impact functional recovery after TKA. "
    Bonus plus!

    Link to study

    Ran a marathon ( Several now) several months after my use of XPERIENCE and Blastx during and after bone graft, new titanium pin and four screws in my Tibia. The swelling and infection on the prior surgical attempt to fix the break in my tibia was not fun!!!!!

    Reducing the drugs! That is a huge benefit. "The XP cohort exhibited a quicker “weaning off opioids” timeline evidenced by the PI cohort reaching half of the maximum percentage of subjects using opioids 8 days later than the XP cohort."
 
watchlist Created with Sketch. Add NXS (ASX) to my watchlist
(20min delay)
Last
15.5¢
Change
0.000(0.00%)
Mkt cap ! $45.28M
Open High Low Value Volume
16.0¢ 16.0¢ 15.5¢ $6.303K 40.65K

Buyers (Bids)

No. Vol. Price($)
2 6575 15.5¢
 

Sellers (Offers)

Price($) Vol. No.
16.0¢ 21952 1
View Market Depth
Last trade - 16.10pm 08/11/2024 (20 minute delay) ?
NXS (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.